Trialtis
Payments companies reported to CMS as associated with Trialtis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Trialtis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Trialtis
These are the largest totals companies reported as associated with Trialtis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Suken Shah | Wilmington, DE | Orthopaedic Surgery | $85,292.97 |
| Eric Klineberg | Sacramento, CA | Orthopaedic Surgery of The Spine | $70,443.01 |
| Munish Gupta | Saint Louis, MO | Orthopaedic Surgery of The Spine | $68,646.42 |
| Baron Lonner | New York, NY | $68,453.38 | |
| Khaled Kebaish | Baltimore, MD | Orthopaedic Surgery | $68,453.38 |
| Daniel Sciubba | Baltimore, MD | Neurological Surgery | $68,177.25 |
| Amer Samdani | Philadelphia, PA | Neurological Surgery | $68,110.28 |
| Brian Kaufman | Austin, TX | Pediatric Orthopaedic Surgery | $17,385.42 |
| Annalise Larson | Rochester, MN | Orthopaedic Surgery | $15,823.85 |
| Joshua Bunch | Kansas City, KS | Orthopaedic Surgery of The Spine | $9,787.09 |
Prescribed Trialtis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.